• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. TENSION FREE VAGINAL TAPE - OBTURATOR UNKNOWN PROD; MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGICAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. TENSION FREE VAGINAL TAPE - OBTURATOR UNKNOWN PROD; MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGICAL Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Fever (1858); Hematoma (1884); Sepsis (2067); Urinary Retention (2119); Urinary Tract Infection (2120); Therapeutic Response, Decreased (2271)
Event Type  Injury  
Manufacturer Narrative
(b)(4).This report is related to a journal article, therefore no product will be returned for analysis and the batch history records cannot be reviewed as the lot number has not been provided.Attempts are being made to obtain the following information.If further details are received at the later date a supplemental medwatch will be sent.Were the cases discussed in this article previously reported to ethicon? if yes, please provide a complaint reference number.Does the surgeon believe that ethicon products involved caused and/or contributed to the post-operative complications described in the article? does the surgeon believe there was any deficiency with the ethicon products used in this procedure? citation: european journal of obstetrics & gynecology and reproductive biology 222 (2018) 146¿150; doi: https://doi.Org/10.1016/j.Ejogrb.2018.01.028.(b)(4).
 
Event Description
It was reported via journal article "title: prevalence and risk factors for urinary tract infection up to one year following midurethral sling incontinence surgery" author: adi y.Weintrauba, yonatan reuvenb, dorit paz-levya, zehava yohaya, inbal idana, debi elharara, hannah glintera, tamar tzurc, david yohaya.Citation: european journal of obstetrics & gynecology and reproductive biology 222 (2018) 146¿150; doi: https://doi.Org/10.1016/j.Ejogrb.2018.01.028.This retrospective cohort study aimed to investigate the prevalence and risk factors of urinary tract infection (uti) one year following sub-midurethral sling (smus) incontinence surgery in a university affiliated medical center in southern israel.Between 2014 and 2015, 178 female patients with stress urinary incontinence underwent smus incontinence surgery.All procedures were transobturator slings (either gynecare tvt abbrevo continence system or gynecare tvt obturator system).Within the first year following the surgery, 38 patients developed uti (mean age sd of 64.8±11.5 years) treated with antibiotics.Three of these patients were complicated with perineal hematoma and one patient had postoperative fever.Of the 140 patients without uti (mean age sd of 61.1±12.3 years), outcome included postoperative fever (n=1), blood transfusion after surgery of the patients who experienced longer hospitalization (>4 days), reasons included urinary retention (n=2) and groin hematoma (n=1).Of the patients who were re-hospitalized within 1 year, reasons included urinary retention (n=1) which resolved spontaneously two days later, pyelonephritis/urosepsis (n=3), suspected infected hematoma in the vaginal stump (n=5), recurrence of prolapse (n=2) and failure of sling (n=1).Twelve patients had recurrent uti.Of the 38 patients with uti, 13 responded to antibiotics and 25 were antibiotic resistant.One of these patient had antibiotic during hospitalization.The authors concluded that antibiotic prophylaxis does not seem to offer any benefit in smus procedures and that pre-operative recurrent uti was the strongest risk factor for postoperative uti.Approximately one in every five women undergoing a smus operation will suffer from uti within 12 months from surgery.This rate is similar to that reported in the literature.A significant association was found between the duration of hospitalization and readmissions in the first postoperative year and suffering from uti.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TENSION FREE VAGINAL TAPE - OBTURATOR UNKNOWN PROD
Type of Device
MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGICAL
Manufacturer (Section D)
ETHICON INC.
p.o. box 151, route 22 west
somerville NJ 08876 0151
Manufacturer (Section G)
ETHICON SARL-NEUCHATEL
puits-godet 20
neuchatel
SZ  
Manufacturer Contact
darlene kyle
p.o. box 151, route 22 west
somerville, NJ 08876-0151
9082182792
MDR Report Key7945093
MDR Text Key123057809
Report Number2210968-2018-76387
Device Sequence Number1
Product Code OTN
Combination Product (y/n)N
Reporter Country CodeIS
PMA/PMN Number
K033568
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,literature
Reporter Occupation Other
Type of Report Initial
Report Date 09/14/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/08/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Date Manufacturer Received09/14/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-